• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 SAFESTEP; PORT ACCESS NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 SAFESTEP; PORT ACCESS NEEDLE Back to Search Results
Model Number N/A
Medical Device Problem Code Activation Problem (4042)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/09/2026
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that after administering fluids with the safestep device, i flushed it with saline and attempted to activate the safestep's safety mechanism.However, the needle only retracted halfway before stopping, preventing the needle tip from being fully retracted.With the needle tip still protruding, i removed the safestep from the patient.There was no reported patient injury.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The device has not been received by the manufacturer for evaluation.Each event reported to bd is evaluated and investigated in accordance with our complaint investigation procedures.The investigation process includes, but is not limited to, evaluation of the event details provided by the complaint facility, a review of complaint history, manufacturing records and risk document where applicable, and an evaluation of the subject device when available to identify potential contributing factors.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The complaint of difficult safety advancement is confirmed and was determined to be related to the manufacture of the product.One 20 ga x 0.75 in.Safestep infusion set was returned for evaluation.An initial visual observation of the returned infusion set showed use residues along the returned device.The safety mechanism was not advanced over the needle shaft upon the return of the infusion set.A microscopic observation revealed excessive adhesive around the metal sleeve of the safety mechanism where the safety mechanism and needle housing interface causing the safety mechanism to stick to the needle housing.No bending was observed along the needle shaft.A functional test of attempting to slide the safety mechanism down the needle shaft revealed some resistance during the attempt.The safety mechanism was able to slide down the needle shaft and safety the needle tip appropriately with some excess force applied to the safety mechanism.The cause of this failure was determined to be related to excessive adhesive application during the manufacture of the product.This complaint will be recorded for future trending and monitoring purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAFESTEP
Common Device Name
PORT ACCESS NEEDLE
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer Contact
becky sparks
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key24208352
Report Number3006260740-2026-00294
Device Sequence Number13168004
Product Code FPA
UDI-Device Identifier00801741066207
UDI-Public(01)00801741066207(11)251028(17)280402(10)ASKRFC021
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K040527
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/12/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue NumberLH-0031
Device Lot NumberASKRFC021
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/13/2026
Supplement Date Received by Manufacturer03/12/2026
Initial Report FDA Received Date01/29/2026
Supplement Report FDA Received Date03/19/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/28/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-